BetterLife Pharma (OTCMKTS:BETRF) Trading 34.8% Higher – Still a Buy?

BetterLife Pharma Inc. (OTCMKTS:BETRFGet Free Report) rose 34.8% during mid-day trading on Thursday . The stock traded as high as $0.12 and last traded at $0.11. Approximately 57,200 shares were traded during trading, an increase of 173% from the average daily volume of 20,967 shares. The stock had previously closed at $0.08.

BetterLife Pharma Stock Up 34.8 %

The company has a 50-day moving average price of $0.08 and a 200-day moving average price of $0.09. The firm has a market capitalization of $14.65 million, a price-to-earnings ratio of -3.77 and a beta of 1.38.

BetterLife Pharma Company Profile

(Get Free Report)

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.

Recommended Stories

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.